Dudediligence.

PMV Pharmaceuticals, Inc

PMVPNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$19.2MSep ’24−$23.0MDec ’24−$17.4MMar ’25−$21.2MJun ’25−$21.1MSep ’25−$18.0MDec ’25−$18.0MMar ’26−$18.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$58.3M−$77.0M−$80.1M−$85.4M−$86.2M
Net income−$57.8M−$73.3M−$69.0M−$58.7M−$77.7M
Operating cash flow−$46.6M−$63.8M−$55.7M−$51.3M−$73.6M
Free cash flow−$47.9M−$71.7M−$56.6M−$51.9M−$73.6M
Cash$172.5M$108.3M$37.7M$40.9M$38.0M
Shares outstanding45.4M45.8M51.4M51.9M53.3M